ArticleNature reviews. Clinical oncology2023
Clash of the titans: axi-cel versus tisa-cel for advanced-stage DLBCL.
Richard T Maziarz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleNature reviews. Clinical oncology2023
Richard T Maziarz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.